CCOc1ccc(C2c3c(-c4ccc(C)cc4)n[nH]c3C(=O)N2c2ccc(Cl)cc2)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?